Table 1. Relations between the level of YB-1 or MACC1 expression and clinicopathologic characteristics in lung adenocarcinoma.
Characteristics | YB-1 | P-value | MACC1 | P-value | ||
---|---|---|---|---|---|---|
High(%) | Low | High(%) | Low | |||
Over all | 80(44.7) | 99 | 92(51.4) | 87 | ||
Sex | 0.761 | 0.489 | ||||
Male | 41(43.6) | 53 | 46 (48.9) | 48 | ||
Female | 39(45.9) | 46 | 46(54.1) | 39 | ||
Age | 0.791 | 0.831 | ||||
≤69y | 42(45.7) | 50 | 48(52.2) | 44 | ||
>69y | 38(43.7) | 49 | 44(50.6) | 43 | ||
TNM stage | <0.001 | <0.001 | ||||
I | 48(34.3) | 92 | 60(42.9) | 80 | ||
II | 13(76.5) | 4 | 12(70.6) | 5 | ||
IIIA | 16 (84.2) | 3 | 17(89.5) | 2 | ||
IIIB/IV | 3(100) | 0 | 3(100) | 0 | ||
T states | <0.001 | 0.033 | ||||
T1 | 40(33.6) | 79 | 54(45.4) | 65 | ||
T2 | 31(62.0) | 19 | 29(58.0) | 21 | ||
T3 | 6 (85.7) | 1 | 6(85.7) | 1 | ||
T4 | 3(100) | 0 | 3(100) | 0 | ||
N states | <0.001 | <0.001 | ||||
N0 | 51(35.4) | 93 | 63(43.8) | 81 | ||
N1 | 13(81.2) | 3 | 12(75.0) | 4 | ||
N2 | 16(84.2) | 3 | 17(89.5) | 2 | ||
Differentiation | 0.038 | 0.416 | ||||
Well | 35(36.1) | 62 | 47(48.5) | 50 | ||
Moderate | 36(53.7) | 31 | 35 (52.2) | 32 | ||
Poor | 9 (60.0) | 6 | 10(66.7) | 5 |